Accuracy Evaluation of the Owlet OSS 3.0-M1 Sensor in Toddlers and Preschoolers
TOPS
1 other identifier
interventional
90
1 country
1
Brief Summary
The purpose of the study is to collect information from the Owlet OSS 3.0-M1 Sensor in toddlers and preschoolers to evaluate accuracy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy
Started Dec 2025
Shorter than P25 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2025
CompletedFirst Submitted
Initial submission to the registry
December 22, 2025
CompletedFirst Posted
Study publicly available on registry
January 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 28, 2026
CompletedJanuary 7, 2026
January 1, 2026
4 months
December 22, 2025
January 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pulse rate accuracy
Average root mean square (ARMS) error between the pulse rate measured by the Owlet OSS 3.0-M1 vs. a reference pulse oximeter
2 hours
SpO2 Accuracy
The average root mean square difference between the Owlet OSS 3.0-M1 Sensor vs. readints from an FDA cleared reference pulse oximeter.
2 hours
Study Arms (1)
Owlet OSS 3.0-M1 Sensor
EXPERIMENTALOwlet OSS 3.0-M1 Sensor accuracy evaluation compared to a reference pulse oximeter.
Interventions
Owlet OSS 3.0-M1 Sensor
Application and monitoring with an FDA cleared reference pulse oximeter
Eligibility Criteria
You may qualify if:
- Subject is between 19 months and ≤ 60 months of age.
- Subject's current body weight is ≥ 6 lbs.
- Subject/legal guardian is fluent in both written and spoken English.
- Subject is willing and able to follow study requirements
- Legal guardian has provided consent.
You may not qualify if:
- Subject has preexisting cardiovascular or respiratory disease or conditions.
- Subjects with abnormalities (e.g., limb deformities, open wounds, severe edema) at the planned application sites that would interfere with system measurements.
- The device(s) are unable to fit properly without risk of injury (e.g., hook of VELCRO is against the skin, wrap is too tight and constricting).
- Subject has skin irritation at the location of device placement.
- Subject has known allergies to adhesive.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vital Signs Research Group, LLC
San Francisco, California, 94107, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Greg Stratmann, MD, PhD
Vital Signs Research Group, LLC
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 22, 2025
First Posted
January 7, 2026
Study Start
December 15, 2025
Primary Completion
March 31, 2026
Study Completion
April 28, 2026
Last Updated
January 7, 2026
Record last verified: 2026-01